Searles Andrew, Doran Evan, Faunce Thomas A, Henry David
Hunter Medical Research Institute, The University of Newcastle, Hunter Valley Research Foundation, Australia.
Aust Health Rev. 2013 Feb;37(1):32-40. doi: 10.1071/AH11153.
To create and report survey-based indicators of the affordability of prescription medicines for patients in Australia.
A cross-sectional study of 1502 randomly selected participants in the Hunter Region of NSW, were interviewed by telephone.
The self-reported financial burden of obtaining prescription medicines.
Data collection was completed with a response rate of 59.0%. Participants who had received and filled at least one prescription medicine in the previous 3 months, and eligible for analysis (n=952), were asked to self-report the level of financial burden from obtaining these medicines. Extreme and heavy financial burdens were reported by 2.1% and 6.8% of participants, respectively. A moderate level of burden was experienced by a further 19.5%. Low burden was recorded for participants who said that their prescription medicines presented either a slight burden (29.0%) or were no burden at all (42.6%).
A substantial minority of participants who had obtained prescription medicines in the 3 months prior to survey experienced a level of financial burden from the cost of these medicines that was reported as being moderate to extreme.
创建并报告基于调查的澳大利亚患者处方药可负担性指标。
对新南威尔士州猎人地区随机选取的1502名参与者进行横断面研究，通过电话进行访谈。
获取处方药的自我报告财务负担。
数据收集完成，应答率为59.0%。在过去3个月内至少收到并填写过一份处方药且符合分析条件的参与者（n = 952），被要求自我报告获取这些药物的财务负担水平。分别有2.1%和6.8%的参与者报告有极端和沉重的财务负担。另有19.5%的参与者经历了中等程度的负担。表示处方药带来轻微负担（29.0%）或完全没有负担（42.6%）的参与者记录为低负担。
在调查前3个月内获取过处方药的相当一部分参与者，因这些药物的费用而经历了被报告为中度至极端的财务负担。
